ACTG is a global clinical trials network that conducts research to improve the management of HIV and its comorbidities; develop a cure for HIV; and innovate treatments for tuberculosis, hepatitis B, and emerging infectious diseases.
Statement on the California Wildfires from ACTG Leadership and DAIDS Therapeutics Research Program Leadership
Our Impact and Reach
Since our founding in 1987, ACTG investigators and sites across four continents have served as major resources for HIV and other infectious disease research, treatment, care, and education in their communities.
47k+
participants
65
sites
15
countries
3k+
trials
Our Trials Locations Worldwide
Botswana
Botswana
Brazil
Haiti
India
Kenya
Malawi
Malawi
Mexico
Mexico
Peru
Peru
South Africa
Thailand
Uganda
USA
USA
Brigham and Women’s Hospital Therapeutics (BWH TCRS) CRS
Massachusetts General Hospital (MGH) CRS
Case Clinical Research Site CRS
Columbia Physicians & Surgeons (P&S) CRS
De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC)
University of California, San Francisco HIV/AIDS CRS
University of Washington Positive Research CRS
Houston AIDS Research Team (HART) CRS
UCSD Antiviral Research Center CRS
University of Colorado Hospital CRS
Harbor University of California Los Angeles Center CRS
University of California, Los Angeles CARE Center CRS
University of Rochester Adult HIV Therapeutic Strategies Network CRS
Vanderbilt Therapeutics (VT) CRS
Washington University Therapeutics (WT) CRS
Vietnam
Vietnam
Zimbabwe
Zimbabwe
Voices for the Community
Sign up to receive the latest updates from ACTG